The value of distinct depressive symptoms (PHQ-9) to differentiate depression severity in cancer survivors: An item response approach.
Saved in:
| Title: | The value of distinct depressive symptoms (PHQ-9) to differentiate depression severity in cancer survivors: An item response approach. |
|---|---|
| Authors: | Donk, Loek J. (AUTHOR), Bickel, Esmée A. (AUTHOR), Krijnen, Wim P. (AUTHOR), Tovote, K. Annika (AUTHOR), Sanderman, Robbert (AUTHOR), Schroevers, Maya J. (AUTHOR), Fleer, Joke (AUTHOR), van der Donk, Loek J (AUTHOR) |
| Source: | Psycho-Oncology. Nov2019, Vol. 28 Issue 11, p2240-2243. 4p. 1 Chart, 1 Graph. |
| Subjects: | Cancer patients, Item response theory, Cancer fatigue |
| Abstract: | Screening for depressive symptoms among cancer survivors is challenged by the overlap of somatic depression symptoms with symptoms of cancer and its treatment. Typical depressive symptoms include cognitive-affective symptoms, such as having a depressed mood and somatic symptoms such as fatigue[1]. In conclusion, our study results point out that both somatic and cognitive-affective symptoms of the PHQ-9 are valuable in measuring symptoms of depression in cancer patients and that the screening purpose determines the relative utility of distinct symptoms. [Extracted from the article] |
| Copyright of Psycho-Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Screening for depressive symptoms among cancer survivors is challenged by the overlap of somatic depression symptoms with symptoms of cancer and its treatment. Typical depressive symptoms include cognitive-affective symptoms, such as having a depressed mood and somatic symptoms such as fatigue[1]. In conclusion, our study results point out that both somatic and cognitive-affective symptoms of the PHQ-9 are valuable in measuring symptoms of depression in cancer patients and that the screening purpose determines the relative utility of distinct symptoms. [Extracted from the article] |
|---|---|
| ISSN: | 10579249 |
| DOI: | 10.1002/pon.5192 |
